Siddarth Raajasekar on Neopterin Association with Stroke and Carotid Endarterectomy
Siddarth Raajasekar, Principal Investigator at The Vital Lab, shared on LinkedIn:
”I am pleased to share that my latest research article has been published in Pteridines (De Gruyter Brill).
Title: Plasma total neopterin and neopterin levels are significantly elevated in stroke patients before carotid endarterectomy surgery
DOI: 10.1515/pteridines-2025-0055
This study provides new clinical evidence linking macrophage-driven inflammatory metabolites—neopterin and total neopterin—to vascular risk in patients undergoing carotid endarterectomy.
It reinforces the translational relevance of immune-redox biomarkers in cerebrovascular disease.
Grateful to my collaborators, mentors, and institutional support for enabling this work.
I look forward to expanding this line of research through the VITAL Lab with upcoming multicentric clinical and computational studies.”
Read the full article here.
Article: Plasma total neopterin and neopterin levels are significantly elevated in stroke patients before carotid endarterectomy surgery
Authors: Siddarth Raajasekar, Justin Roake, Vicky Cameron, Ruth Benson, Anna Pilbrow, Steven Gieseg

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator